Cost-effectiveness of a community-based exercise programme in COPD self-management

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 13, Issue 2, 2016, Pages 214-223

  Zwerink, Marlies ^a   Effing, Tanja ^b,c   Kerstjens, Huib A M ^d   Van Der Valk, Paul ^a   Brusse Keizer, Marjolein ^a   Zielhuis, Gerhard ^e   Van Der Palen, Job ^a,f  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

community based; COPD; costeffectiveness; exercise; physical activity; selfmanagement

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EXERCISE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PHYSIOTHERAPIST; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SELF CARE; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; COST BENEFIT ANALYSIS; ECONOMICS; KINESIOTHERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TIME FACTOR;

COST-BENEFIT ANALYSIS; EXERCISE; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES; SELF CARE; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84948735900     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2015.1074171     Document Type: Article

References (31)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2014. Available from http://www.goldcopd.org [Accessed 2014 June 16]
2. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171 (9): 972-977.
3. Spruit MA, Singh SJ, Garvey C, et al. An official american thoracic society/european respiratory society statement: key concepts and advances in pulmonary rehabilitation. Amer J Respir Crit Care Med 2013; 188 (8): e13-e64.
4. Troosters T, Sciurba F, Battaglia S, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010; 104 (7): 1005-1011.
5. Watz H, Waschki B, Meyer T, et al. Physical activity in patients with COPD. Eur Respir.J 2009; 33 (2): 262-272.
6. Effing T, Zielhuis G, Kerstjens H, et al. Community based physiotherapeutic exercise in COPD self-management: a randomised controlled trial. Respir Med 2011; 105 (3): 418-426.
7. Gibson GJ, Loddenkemper R, Sibille Y, Lundbäck B. The European Lung White Book. Sheffield, UK: European Respiratory Society, 2013.
8. Suijkerbuijk AW, de Wit GA, Wijga AH, et al. [Societal costs of asthma, COPD and respiratory allergy]. Ned Tijdschr Geneeskd 2013; 57 (46): A6562.
9. Bourbeau J, Collet JP, Schwartzman K, et al. Economic benefits of self-management education in COPD. Chest 2006; 130 (6): 1704-1711.
10. Gallefoss F, Bakke PS. Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD-a 1-year follow-up randomized, controlled trial. Respir.Med 2002; 96 (6): 424-431.
11. Khdour MR, Agus AM, Kidney JC, et al. Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD. Int.J Clin Pharm 2011; 33 (4): 665-673.
12. Monninkhof E, van der Valk P, Schermer T, et al. Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease. Chron Respir Dis 2004; 1 (1): 7-16.
13. Hoogendoorn M, van Wetering CR, Schols AM, et al. Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur Respir J 2010; 35 (1): 79-87.
14. Effing T, Kerstjens H, van der Valk P, et al. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009; 64 (11): 956-962.
15. Zwerink M, van der Palen J, Kerstjens HA, et al. A community-based exercise programme in COPD self-management: two years follow-up of the COPE-II study. Respir Med 2014 Oct; 108 (10): 1481-1490.
16. Singh SJ, Morgan MD, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47 (12): 1019-1024.
17. Singh SJ, Jones PW, Evans R, et al. Minimum clinically important improvement for the incremental shuttle walking test. Thorax 2008; 63 (9): 775-777.
18. Brooks R. EuroQol: The current state of play. Health Pol 1996; 37 (1): 53-72.
19. Dolan P. Modeling valuations for EuroQol health states. Med.Care 1997; 35 (11): 1095-1108.
20. Hakkaart-van Roijen L, Tan, SS, Bouwmans CAM. Handleiding voor kostenonderzoek. College voor Zorgverzekeringen, 2010.
21. van Wetering CR, Hoogendoorn M, Mol SJ, et al. Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010; 65 (1): 7-13.
22. Lacasse Y, Martin S, Lasserson TJ, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura.Medicophys. 2007; 43 (4): 475-485.
23. Beauchamp MK, Evans R, Janaudis-Ferreira T, et al. Systematic review of supervised exercise programs after pulmonary rehabilitation in individuals with COPD. Chest 2013 Oct; 144 (4): 1124-33.
24. Spruit MA, Singh SJ. Maintenance programs after pulmonary rehabilitation: how may we advance this field? Chest 2013; 144 (4): 1091-1093.
25. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am.J.Respir.Crit Care Med. 2007; 175 (5): 458-463.
26. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61 (9): 772-778.
27. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140 (2): 331-342.
28. McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 2008; 26 (9): 733-744.
29. Ligtenberg G, Staal PC, Goettsch WG, Knies S. Kosteneffectiviteit in de zorg. College voor Zorgverzekeringen; 2013. Available from https://www.rijksoverheid.nl/binaries/rijksoverheid/documenten/rapporten/2013/09/30/kosteneffectiviteit-in-de-zorg/kosteneffectiviteit-in-de-zorg.pdf, [cited 2014 July 1]
30. van Gils PF, Schoemaker CG, Polder JJ. [How much should a gained life-year cost? Study on the assessment of a QALY]. Ned Tijdschr Geneeskd 2013; 157 (52): A6507.
31. Raad voor de Volksgezondheid en Zorg. Zinnige en duurzame zorg. 2006. Available from: http://www.raadrvs.nl/uploads/docs/Achtergrondstudie-Zicht-op-zinnige-en-duurzame-zorg.pdf, [cited 2014 July 1]